(HealthDay News) -- Here are the latest clinical trials,
Type 2 Diabetes
This study will evaluate different doses of approved type 2
diabetes drugs. You may qualify if you are aged 18 to 85, have type
2 diabetes, and have been on a stable regimen of NPH insulin,
Levemir (insulin determir), or Lantus (insulin glargine) and at
least one oral diabetic drug for three months.
The research site is in Las Vegas, Nev.
This study will evaluate a nasal spray to treat migraines.
Participants must be aged 12 to 17 and be willing to treat one
migraine with the study drug exclusively.
The research site is in Colorado Springs, Colo.
This study will evaluate an injected study medication in
treating systemic lupus erythematosus (SLE). To qualify, you must
not have had an active infection in the last 30 days, and not have
a serious infection or blood-clotting event within 90/180 days
The research site is in Sacramento, Calif.
ClinicalConnection.com. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.